1. Home
  2. KYTX vs BOOM Comparison

KYTX vs BOOM Comparison

Compare KYTX & BOOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYTX
  • BOOM
  • Stock Information
  • Founded
  • KYTX 2018
  • BOOM 1965
  • Country
  • KYTX United States
  • BOOM United States
  • Employees
  • KYTX N/A
  • BOOM N/A
  • Industry
  • KYTX
  • BOOM Industrial Specialties
  • Sector
  • KYTX
  • BOOM Industrials
  • Exchange
  • KYTX NYSE
  • BOOM Nasdaq
  • Market Cap
  • KYTX 166.4M
  • BOOM 149.2M
  • IPO Year
  • KYTX 2024
  • BOOM N/A
  • Fundamental
  • Price
  • KYTX $3.41
  • BOOM $7.31
  • Analyst Decision
  • KYTX Buy
  • BOOM Buy
  • Analyst Count
  • KYTX 5
  • BOOM 2
  • Target Price
  • KYTX $23.20
  • BOOM $16.00
  • AVG Volume (30 Days)
  • KYTX 308.0K
  • BOOM 170.6K
  • Earning Date
  • KYTX 02-12-2025
  • BOOM 02-20-2025
  • Dividend Yield
  • KYTX N/A
  • BOOM N/A
  • EPS Growth
  • KYTX N/A
  • BOOM N/A
  • EPS
  • KYTX N/A
  • BOOM N/A
  • Revenue
  • KYTX N/A
  • BOOM $664,513,000.00
  • Revenue This Year
  • KYTX N/A
  • BOOM N/A
  • Revenue Next Year
  • KYTX N/A
  • BOOM N/A
  • P/E Ratio
  • KYTX N/A
  • BOOM N/A
  • Revenue Growth
  • KYTX N/A
  • BOOM N/A
  • 52 Week Low
  • KYTX $3.22
  • BOOM $6.65
  • 52 Week High
  • KYTX $30.60
  • BOOM $19.72
  • Technical
  • Relative Strength Index (RSI)
  • KYTX 37.34
  • BOOM 41.48
  • Support Level
  • KYTX $3.22
  • BOOM $7.35
  • Resistance Level
  • KYTX $3.53
  • BOOM $7.84
  • Average True Range (ATR)
  • KYTX 0.25
  • BOOM 0.36
  • MACD
  • KYTX 0.00
  • BOOM 0.05
  • Stochastic Oscillator
  • KYTX 13.46
  • BOOM 4.76

About KYTX KYVERNA THERAPEUTICS INC

Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

Share on Social Networks: